{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-005273","form_type":"8-K","ticker":"AHCO","cik":"0001725255","company_name":"AdaptHealth Corp.","filed_at":"2023-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.324702+00:00","generated_at":"2026-06-18T23:48:55.828024+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"AdaptHealth reports Q4 net loss, cuts 2023 guidance on cost pressures and revenue mix","bullets":["Full-year 2022 net revenue up 21% YoY; net income $69.3M ($0.33/diluted) vs $156.2M ($0.67) in 2021.","Q4 net loss $2.6M ($(0.02)/share) vs net income $22.9M ($0.15) in Q4 2021; adjusted EBITDA $146.0M, down 7.7% YoY.","2023 guidance cut: revenue $3.160B-$3.240B (prev $3.210B-$3.290B); adj. EBITDA $650M-$710M (prev $690M-$750M).","CEO cites larger-than-expected revenue mix and cost pressures for EBITDA miss; new cost containment programs planned.","Cash flow from operations $373.9M in 2022, up from $275.7M in 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-005273","json":"https://secwatch.observer/filing/0001628280-23-005273.json","markdown":"https://secwatch.observer/filing/0001628280-23-005273.md","text":"https://secwatch.observer/filing/0001628280-23-005273.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725255/000162828023005273/0001628280-23-005273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725255/000162828023005273/ahco-20230227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T23:48:55.828024+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"14b2ee5a0ac31d85bb801bd06ada1fcca08b1f01","claim":"AdaptHealth Corp. reported fiscal year 2023 results: revenue Net revenue of $3.160 billion to $3.240 billion. Guidance lowered.","evidence_excerpt":"The Company is updating its initial financial guidance for fiscal year 2023, as follows: • Net revenue of $3.160 billion to $3.240 billion (previously $3.210 billion to $3.290 billion); • Adjusted EBITDA of $650 million to $710 million (previously $690 million to $750 million); • Total capital expenditures representing 10-12% of net revenue (previously 9-11% of net revenue).","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725255/000162828023005273/0001628280-23-005273-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year 2023"},{"label":"Revenue","value":"Net revenue of $3.160 billion to $3.240 billion"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"327898b07de40f850f57df0c64456899945cf80a","claim":"AdaptHealth Corp. reported the fourth quarter of 2022 results: revenue $780.3 million, net income Net loss attributable to AdaptHealth Corp. was $2.6 million, or $(0.02) per diluted share, EPS $(0.02) per diluted share.","evidence_excerpt":"AdaptHealth reported Net revenue of $780.3 million for the fourth quarter of 2022 compared to $702.1 million in the fourth quarter of 2021, an increase of 11.1% including non-acquired growth of 5.3%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725255/000162828023005273/0001628280-23-005273-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter of 2022"},{"label":"Revenue","value":"$780.3 million"},{"label":"Net income","value":"Net loss attributable to AdaptHealth Corp. was $2.6 million, or $(0.02) per diluted share"},{"label":"EPS","value":"$(0.02) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"372f66ddd4a67d3f1ab1a04b7ed1ce4a7d93a1b2","claim":"AdaptHealth Corp. reported the fiscal year ended December 31, 2022 results: net income Net income attributable to AdaptHealth Corp. was $69.3 million, or $0.33 per diluted share, EPS $0.33 per diluted share.","evidence_excerpt":"Net income attributable to AdaptHealth Corp. was $69.3 million, or $0.33 per diluted share, compared to $156.2 million, or $0.67 per diluted share, in 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725255/000162828023005273/0001628280-23-005273-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2022"},{"label":"Net income","value":"Net income attributable to AdaptHealth Corp. was $69.3 million, or $0.33 per diluted share"},{"label":"EPS","value":"$0.33 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}